BAHD1

Across TCGA pan-cancer cohorts, BAHD1 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of BAHD1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where BAHD1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BAHD1 is over-expressed in tumor, although a few such as KIRC and COAD show the opposite, repressed pattern.

HNSC, LIHC, and KIRC are the cancer types where BAHD1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BAHD1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	III,IV	+0.718	<.001	11	view →
LIHC	All	III,IV	+0.913	<.001	9	view →
KIRC	Male	II,III,IV	−0.539	<.001	6	view →
COAD	Female	II,III,IV	−0.467	<.001	5	view →
CHOL	All	II,III,IV	+1.339	.001	4	view →
LUAD	All	All	−0.394	<.001	3	view →
READ	All	All	−0.553	.003	2	view →
UCEC	All	All	−0.521	.026	2	view →
KICH	Female	II,III,IV	+0.512	.015	2	view →
KIRP	All	All	−0.318	.007	2	view →
STAD	Male	II,III,IV	+0.599	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

BAHD1–HNSC

Open the HNSC breakdown →